Pathologie Friesland

What Pathologie Friesland does

Pathologie Friesland is a regional medical pathology laboratory headquartered in Leeuwarden, Netherlands, providing clinical pathological diagnostics, autopsy services, and participation in national population screening programs to hospitals, general practitioners, and patients across Friesland and surrounding areas in Northern Netherlands. Its service portfolio centers on histological and cytological diagnostic examinations, supplemented by autopsy and screening program work. The lab is part of the Pathologie Noord cooperative alongside UMCG, Martini Ziekenhuis, and Treant Zorggroep, collectively performing more than 200,000 examinations annually across Friesland, Groningen, Drenthe, and the Noordoostpolder.

Operationally, Pathologie Friesland operates a sales-led, regional B2B model. Hospital pathology departments and primary care physicians order tests through dedicated forms and, increasingly, through the ZorgDomein platform (mandatory from 1 April 2026); specimen transport follows published regional schedules. Pricing is structured as professional service fees for diagnostic examinations, with a publicly referenced but undisclosed rates page for general practitioners. The lab is ISO 15189 accredited (registration M282, valid until 01-06-2027) and GDPR/AVG compliant.

The technology stack centers on a digital pathology platform implemented via Concentriq from Proscia, enabling digitization of slides, remote viewing, and intra-cooperative image exchange among pathologists. Computer vision algorithms are applied to specific diagnostic workflows including Ki67 hotspot detection and HER2 immunohistochemistry scoring. Distribution is via direct enterprise relationships with regional hospitals and a digital ordering channel for general practitioners, with no public API or consumer-facing app. Near-term strategic activity focuses on the 2026 Concentriq rollout, the ZorgDomein transition, and exploratory merger discussions with Treant and Martini Ziekenhuis pathology departments that could consolidate Northern Netherlands pathology services into a single organization from 2027.

Name

Pathologie Friesland

Legal name

Pathologie Friesland

Website

https://pathologiefriesland.nl

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Pathologie Friesland is a regional medical pathology laboratory in Leeuwarden, Netherlands, providing clinical pathology diagnostics, autopsy, and population screening services to hospitals and general practitioners in Friesland and surrounding areas as part of the Pathologie Noord cooperative.

Ownership category

akta.pro rank

Product category

Medical Laboratory Diagnostics

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

Keywords

• Pathology diagnostics
• Clinical laboratory services
• Digital pathology
• Autopsy services
• Population screening

Headquarters

HQ city

Leeuwarden

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Pathology Diagnostics Services: Laboratory diagnostic services for tissue analysis, cytology, and autopsies provided to hospitals and general practitioners in the Friesland region. Services include screening tests and population-based screening programs.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

Pathologie Friesland provides clinical pathology diagnostic services including histological and cytological examinations, autopsy procedures, and participation in national population screening programs for hospitals, general practitioners, and other healthcare providers in Friesland and the wider Northern Netherlands region. It operates a digital pathology platform (Concentriq by Proscia) and accepts diagnostic requests electronically through the ZorgDomein platform.

Product overview

Pathologie Friesland operates as a regional medical pathology laboratory providing diagnostic services to hospitals, general practitioners, and healthcare providers in Friesland and surrounding areas. The organization functions as part of the Pathologie Noord cooperative alongside UMCG, Martini Ziekenhuis, and Treant Zorggroep, collectively performing over 200,000 examinations annually. The service portfolio centers on core pathology diagnostics encompassing histological and cytological analysis, augmented by digital pathology capabilities through the Concentriq platform, autopsy services, and participation in population screening programs. An electronic diagnostic request system via ZorgDomein enables general practitioners to submit pathology requests digitally.

Differentiator

Problem solved

Functional benefit

Brands

• Pathologie Noord: A cooperative formed by UMCG, Martini Ziekenhuis, Treant Zorggroep, and Pathologie Friesland for providing pathology diagnostics for general practitioners and hospitals in Friesland, Groningen, Drenthe, and part of the Noordoostpolder.

Products and services

• Clinical Pathology Diagnostics (Histology and Cytology) Comprehensive clinical pathology diagnostic services including histological and cytological examinations of tissue and cell samples, serving hospitals, general practitioners, and other healthcare providers in Friesland and surrounding regions.
• Autopsy (Obductie) Services Post-mortem examination services to determine cause of death and investigate disease processes, including external and internal examination of organs, brain examination, and special investigations for hereditary diseases or infectious conditions. Available to hospitals and general practitioners.
• Population Screening Programs Participation in various national population screening programs as part of the Pathologie Noord cooperative, contributing to early detection of diseases including bowel cancer screening.
• Digital Pathology Platform (Concentriq by Proscia) Digital pathology platform enabling digitization of pathology slides, remote viewing, and collaborative analysis across the Pathologie Noord cooperative. Serves as the foundation for flexible image processing workflows and preparation for future digital pathology needs, allowing pathologists to exchange digital images and rapidly consult each other.

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature2 records

Partnerships

Three partnerships are on record, tiered core.

• ZorgDomeincoreTechnology or Integration · 2 February 2026ZorgDomein platform used for diagnostic requests from general practitioners. Transition period until April 1, 2026, after which only pathology requests via ZorgDomein will be accepted.
• ProsciacoreTechnology or Integration · 1 January 2026Pathologie Friesland is implementing Concentriq from Proscia as the foundation for a flexible image processing system to prepare for the future of digital pathology.
• Pathologie NoordcoreStrategic or Co-development PartnerCooperative formed by UMCG, Martini Ziekenhuis, Treant Zorggroep, and Pathologie Friesland to provide pathology diagnostics for general practitioners and hospitals in Friesland, Groningen, Drenthe, and part of Noordoostpolder. Members perform more than 200,000 examinations per year together. Key focus on implementing digital pathology for image exchange and rapid consultation.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Labcorp: Labcorp is a large global clinical-laboratory network with a dedicated anatomic pathology business serving hospitals, health systems, and physicians. It is a broad incumbent comparable on clinical-pathology services and on digital-pathology investments, even though its geographic footprint is largely North American.
• Sonic Healthcare: Sonic Healthcare is a global medical diagnostics group with substantial anatomic pathology capacity across Europe, Australia, and the US through brands such as The Doctor's Laboratory and Bioscientia. It is a relevant broad incumbent comparable in clinical-pathology services and digital-pathology infrastructure.
• Quest Diagnostics: Quest Diagnostics operates one of the largest clinical laboratory and anatomic pathology service networks in the world, providing histologic, cytologic, and molecular diagnostic services to hospitals and physicians. It is a public-market broad incumbent comparable on the clinical-pathology service model, though primarily serving a North American customer base.
• Unilabs: Unilabs is a major European clinical laboratory and pathology operator offering histology, cytology, and digital pathology services to hospitals and referring physicians. Its scale and pan-European digital-pathology footprint make it a broad incumbent comparator that could bid on contracts similar to Pathologie Friesland's if it expands further in the Netherlands.
• Synlab: Synlab is one of Europe's largest medical diagnostic services networks, operating hundreds of clinical laboratories across histology, cytology, and molecular diagnostics. Although much larger and geographically broader than Pathologie Friesland, it offers the same core anatomic pathology service line and competes for hospital and screening contracts in overlapping Dutch territories.
• Cerba Healthcare: Cerba Healthcare is a European clinical-pathology and specialty-laboratory network providing anatomic pathology, biopsy interpretation, and screening diagnostics across multiple countries. It is a broad incumbent in the same anatomic-pathology category and increasingly targets hospital pathology outsourcing contracts comparable to Pathologie Friesland's cooperative referral stream.

Direct peers

• LabPON: LabPON is a regional medical-pathology laboratory serving hospitals and GPs in East Netherlands with histology, cytology, and molecular pathology services. It is the closest geographic and operating-model comparable to Pathologie Friesland, with a similar mix of regional referral base, digital pathology adoption, and participation in national screening programs.

Others

• Sectra: Sectra provides digital pathology PACS and image-management solutions widely used by European pathology laboratories and academic centers. It is an ecosystem enabler — a possible alternative or complementary vendor to Proscia — rather than a direct competitor to Pathologie Friesland's diagnostic service business.
• Philips Digital Pathology: Philips offers digital pathology scanner and workflow solutions used across European hospital pathology departments. As a Dutch medtech vendor, it is an adjacent infrastructure provider to Pathologie Friesland's planned digital-pathology stack rather than a peer in clinical-pathology services.
• Proscia: Proscia is a US-based digital pathology software vendor whose Concentriq platform is being implemented by Pathologie Friesland. It is an enabling technology partner rather than a competitor — directly relevant for understanding the lab's path toward AI-augmented diagnostic workflows and platform dependencies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/524110331043281
• LinkedInlinkedin.com/company/pathologie-friesland

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pathologie Friesland